One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-124492
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 17 |
Affiliation: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, The Ohio State University, James Cancer Hospital, Novartis (Switzerland), Novartis (India), Peter MacCallum Cancer Centre, University of Melbourne, Oregon Health & Science University, Vienna General Hospital, Medical University of Vienna, Emory University, Cornell University, Oslo University Hospital, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Hokkaido University Hospital, University of Cologne, University Hospital Cologne, Tokyo National Hospital, University of Würzburg, Université de Montréal, Hôpital Maisonneuve-Rosemont, University of Kansas, University of Pennsylvania, University of Minnesota, Tris Pharma (United States), University of Chicago, Hôpital Lyon Sud, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, University of Michigan–Ann Arbor, Royal Prince Alfred Hospital, Kyushu University, Hamilton Health Sciences, University of Amsterdam, Academic Medical CenterCorrelation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
